<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>bio money</title>
		<link>https://biospectrumasia.com/rssfeed/specials/bio%20money</link>
		<atom:link href="https://biospectrumasia.com/rssfeed/specials/bio%20money" rel="self" type="application/rss+xml" />
		<description>bio money</description>
					<item>
			<title>Birgit Girshick Puts Charles River’s Recovery in Focus as Organic Growth Reaches 4.7%</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/28645/birgit-girshick-puts-charles-rivers-recovery-in-focus-as-organic-growth-reaches-4-7.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/28645/birgit-girshick-puts-charles-rivers-recovery-in-focus-as-organic-growth-reaches-4-7.html</link>
			<pubDate>Thu, 05 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-28645.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/28645/birgit-girshick-puts-charles-rivers-recovery-in-focus-as-organic-growth-reaches-4-7.html</guid>
		</item>	
				<item>
			<title>WuXi AppTec Raises 2026 Revenue Outlook to RMB 61.9 Billion as Nine-Month Profit Surges 74.4%</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/28585/wuxi-apptec-raises-2026-revenue-outlook-to-rmb-61-9-billion-as-nine-month-profit-surges-74-4.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/28585/wuxi-apptec-raises-2026-revenue-outlook-to-rmb-61-9-billion-as-nine-month-profit-surges-74-4.html</link>
			<pubDate>Mon, 26 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28585.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/28585/wuxi-apptec-raises-2026-revenue-outlook-to-rmb-61-9-billion-as-nine-month-profit-surges-74-4.html</guid>
		</item>	
				<item>
			<title>EQT to Acquire QIAGEN in Landmark €10.8 Billion Take-Private Deal</title>
			<atom:link href="https://biospectrumasia.com/news/102/28562/eqt-to-acquire-qiagen-in-landmark-10-8-billion-take-private-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/28562/eqt-to-acquire-qiagen-in-landmark-10-8-billion-take-private-deal.html</link>
			<pubDate>Thu, 22 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1792614167328-28562.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/28562/eqt-to-acquire-qiagen-in-landmark-10-8-billion-take-private-deal.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher Scientific Hits $12.14 Billion in Q3 Revenue as Innovation Fuels Double-Digit Earnings Growth</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/28563/thermo-fisher-scientific-hits-12-14-billion-in-q3-revenue-as-innovation-fuels-double-digit-earnings-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/28563/thermo-fisher-scientific-hits-12-14-billion-in-q3-revenue-as-innovation-fuels-double-digit-earnings-growth.html</link>
			<pubDate>Thu, 22 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28563.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/28563/thermo-fisher-scientific-hits-12-14-billion-in-q3-revenue-as-innovation-fuels-double-digit-earnings-growth.html</guid>
		</item>	
				<item>
			<title>Most Assets Die on Fit, Not on Data</title>
			<atom:link href="https://biospectrumasia.com/news/102/28308/most-assets-die-on-fit-not-on-data.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/28308/most-assets-die-on-fit-not-on-data.html</link>
			<pubDate>Wed, 02 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_partnering_priorities_under_400kb-28308.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/28308/most-assets-die-on-fit-not-on-data.html</guid>
		</item>	
				<item>
			<title>Two Days That Mapped the Next Phase of APAC Dealmaking</title>
			<atom:link href="https://biospectrumasia.com/news/102/28309/two-days-that-mapped-the-next-phase-of-apac-dealmaking.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/28309/two-days-that-mapped-the-next-phase-of-apac-dealmaking.html</link>
			<pubDate>Wed, 02 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_abpf_collage_under_400kb-28309.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/28309/two-days-that-mapped-the-next-phase-of-apac-dealmaking.html</guid>
		</item>	
				<item>
			<title>China Biotech’s Global Breakout: Innovation, Deals and the Next Investment Cycle</title>
			<atom:link href="https://biospectrumasia.com/influencers/102/28246/china-biotechs-global-breakout-innovation-deals-and-the-next-investment-cycle.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/102/28246/china-biotechs-global-breakout-innovation-deals-and-the-next-investment-cycle.html</link>
			<pubDate>Mon, 24 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_yang_huang_interview_under_400kb-28246.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/102/28246/china-biotechs-global-breakout-innovation-deals-and-the-next-investment-cycle.html</guid>
		</item>	
				<item>
			<title>The Translation Problem</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/28169/the-translation-problem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/28169/the-translation-problem.html</link>
			<pubDate>Sat, 08 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/84235717_af02_47c0_9df1_3d59274741b9-28169.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/28169/the-translation-problem.html</guid>
		</item>	
				<item>
			<title>Biotech&#039;s New Rules: Data, Discipline and the Return of Capital</title>
			<atom:link href="https://biospectrumasia.com/influencers/102/27859/biotechs-new-rules-data-discipline-and-the-return-of-capital.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/102/27859/biotechs-new-rules-data-discipline-and-the-return-of-capital.html</link>
			<pubDate>Mon, 22 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/david_crean_biospectrum_asia_under_400kb-27859.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/102/27859/biotechs-new-rules-data-discipline-and-the-return-of-capital.html</guid>
		</item>	
				<item>
			<title>Sanofi Successfully Prices â‚¬1.5 Billion Offering Under Euro Medium Term Note Program</title>
			<atom:link href="https://biospectrumasia.com/news/102/25688/sanofi-successfully-prices-1-5-billion-offering-under-euro-medium-term-note-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/25688/sanofi-successfully-prices-1-5-billion-offering-under-euro-medium-term-note-program.html</link>
			<pubDate>Thu, 06 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-25688.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/25688/sanofi-successfully-prices-1-5-billion-offering-under-euro-medium-term-note-program.html</guid>
		</item>	
				<item>
			<title>Amgen&#039;s 2024 Revenue Soars 19% Amid Strong Product Sales and Strategic Investments</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25637/amgens-2024-revenue-soars-19-amid-strong-product-sales-and-strategic-investments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25637/amgens-2024-revenue-soars-19-amid-strong-product-sales-and-strategic-investments.html</link>
			<pubDate>Wed, 26 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-25637.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25637/amgens-2024-revenue-soars-19-amid-strong-product-sales-and-strategic-investments.html</guid>
		</item>	
				<item>
			<title>Bristol Myers Squibb Caps 2024 with Strong Q4 Growth, Bolstered by Key Products and Pipeline Advances</title>
			<atom:link href="https://biospectrumasia.com/analysis/102/25638/bristol-myers-squibb-caps-2024-with-strong-q4-growth-bolstered-by-key-products-and-pipeline-advances.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/102/25638/bristol-myers-squibb-caps-2024-with-strong-q4-growth-bolstered-by-key-products-and-pipeline-advances.html</link>
			<pubDate>Wed, 26 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_1-25638.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/102/25638/bristol-myers-squibb-caps-2024-with-strong-q4-growth-bolstered-by-key-products-and-pipeline-advances.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk Delivers Strong 2024 Results with 26% Revenue Growth, Fueled by GLP-1 Success and Obesity Market Expansion</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25639/novo-nordisk-delivers-strong-2024-results-with-26-revenue-growth-fueled-by-glp-1-success-and-obesity-market-expansion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25639/novo-nordisk-delivers-strong-2024-results-with-26-revenue-growth-fueled-by-glp-1-success-and-obesity-market-expansion.html</link>
			<pubDate>Wed, 26 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_2-25639.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25639/novo-nordisk-delivers-strong-2024-results-with-26-revenue-growth-fueled-by-glp-1-success-and-obesity-market-expansion.html</guid>
		</item>	
				<item>
			<title>AstraZeneca Reports Strong Q4 2024 Growth with $14.89 Billion Revenue, Driven by Oncology and Innovative Therapies</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25586/astrazeneca-reports-strong-q4-2024-growth-with-14-89-billion-revenue-driven-by-oncology-and-innovative-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25586/astrazeneca-reports-strong-q4-2024-growth-with-14-89-billion-revenue-driven-by-oncology-and-innovative-therapies.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-25586.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25586/astrazeneca-reports-strong-q4-2024-growth-with-14-89-billion-revenue-driven-by-oncology-and-innovative-therapies.html</guid>
		</item>	
				<item>
			<title>Biogen Reports Q4 and Full-Year 2024 Results: Strong EPS Growth Amid Revenue Challenges</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25587/biogen-reports-q4-and-full-year-2024-results-strong-eps-growth-amid-revenue-challenges.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25587/biogen-reports-q4-and-full-year-2024-results-strong-eps-growth-amid-revenue-challenges.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_1-25587.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25587/biogen-reports-q4-and-full-year-2024-results-strong-eps-growth-amid-revenue-challenges.html</guid>
		</item>	
				<item>
			<title>Eli Lilly Reports Record Q4 2024 Revenue of $13.53B, Fueled by Mounjaro, Zepbound, and Oncology Growth</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25588/eli-lilly-reports-record-q4-2024-revenue-of-13-53b-fueled-by-mounjaro-zepbound-and-oncology-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25588/eli-lilly-reports-record-q4-2024-revenue-of-13-53b-fueled-by-mounjaro-zepbound-and-oncology-growth.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_2-25588.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25588/eli-lilly-reports-record-q4-2024-revenue-of-13-53b-fueled-by-mounjaro-zepbound-and-oncology-growth.html</guid>
		</item>	
				<item>
			<title>GSK Reports Strong Q4 2024 Growth in Specialty Medicines and HIV, Offsetting Vaccine Declines</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25589/gsk-reports-strong-q4-2024-growth-in-specialty-medicines-and-hiv-offsetting-vaccine-declines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25589/gsk-reports-strong-q4-2024-growth-in-specialty-medicines-and-hiv-offsetting-vaccine-declines.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_3-25589.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25589/gsk-reports-strong-q4-2024-growth-in-specialty-medicines-and-hiv-offsetting-vaccine-declines.html</guid>
		</item>	
				<item>
			<title>Moderna Reports $966M Q4 2024 Revenue Amid COVID-19 Vaccine Decline, Focuses on mRNA Pipeline Expansion</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25590/moderna-reports-966m-q4-2024-revenue-amid-covid-19-vaccine-decline-focuses-on-mrna-pipeline-expansion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25590/moderna-reports-966m-q4-2024-revenue-amid-covid-19-vaccine-decline-focuses-on-mrna-pipeline-expansion.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-25590.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25590/moderna-reports-966m-q4-2024-revenue-amid-covid-19-vaccine-decline-focuses-on-mrna-pipeline-expansion.html</guid>
		</item>	
				<item>
			<title>Novartis Reports Strong Q4 2024 with 16% Sales Growth, Driven by Cardiovascular, Oncology, and Immunology Therapies</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25591/novartis-reports-strong-q4-2024-with-16-sales-growth-driven-by-cardiovascular-oncology-and-immunology-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25591/novartis-reports-strong-q4-2024-with-16-sales-growth-driven-by-cardiovascular-oncology-and-immunology-therapies.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_4-25591.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25591/novartis-reports-strong-q4-2024-with-16-sales-growth-driven-by-cardiovascular-oncology-and-immunology-therapies.html</guid>
		</item>	
				<item>
			<title>Pfizer Reports Strong Q4 2024 with $17.8B Revenue, Driven by Oncology and Cardiovascular Growth</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25592/pfizer-reports-strong-q4-2024-with-17-8b-revenue-driven-by-oncology-and-cardiovascular-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25592/pfizer-reports-strong-q4-2024-with-17-8b-revenue-driven-by-oncology-and-cardiovascular-growth.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-25592.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25592/pfizer-reports-strong-q4-2024-with-17-8b-revenue-driven-by-oncology-and-cardiovascular-growth.html</guid>
		</item>	
				<item>
			<title>SK Bioscience Reports 73% Revenue Growth in Q4 2024, Driven by IDT Biologika Acquisition and Vaccine Expansionv</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25593/sk-bioscience-reports-73-revenue-growth-in-q4-2024-driven-by-idt-biologika-acquisition-and-vaccine-expansionv.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25593/sk-bioscience-reports-73-revenue-growth-in-q4-2024-driven-by-idt-biologika-acquisition-and-vaccine-expansionv.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-25593.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25593/sk-bioscience-reports-73-revenue-growth-in-q4-2024-driven-by-idt-biologika-acquisition-and-vaccine-expansionv.html</guid>
		</item>	
				<item>
			<title>Takeda Reports Strong Q4 2024 Performance with 9.8% Revenue Growth, Driven by Oncology and Plasma-Derived Therapies</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25594/takeda-reports-strong-q4-2024-performance-with-9-8-revenue-growth-driven-by-oncology-and-plasma-derived-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25594/takeda-reports-strong-q4-2024-performance-with-9-8-revenue-growth-driven-by-oncology-and-plasma-derived-therapies.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_finanacilla_review-25594.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25594/takeda-reports-strong-q4-2024-performance-with-9-8-revenue-growth-driven-by-oncology-and-plasma-derived-therapies.html</guid>
		</item>	
				<item>
			<title>Teva Reports $4.2B Q4 2024 Revenue as Specialty Medicines and Biosimilars Drive Growth</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/25595/teva-reports-4-2b-q4-2024-revenue-as-specialty-medicines-and-biosimilars-drive-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/25595/teva-reports-4-2b-q4-2024-revenue-as-specialty-medicines-and-biosimilars-drive-growth.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_1-25595.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/25595/teva-reports-4-2b-q4-2024-revenue-as-specialty-medicines-and-biosimilars-drive-growth.html</guid>
		</item>	
				<item>
			<title>Singapore commits S$440 million in funding to drive growth of deep tech through partnerships with prominent global VCs</title>
			<atom:link href="https://biospectrumasia.com/news/102/25140/singapore-commits-s440-million-in-funding-to-drive-growth-of-deep-tech-through-partnerships-with-prominent-global-vcs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/25140/singapore-commits-s440-million-in-funding-to-drive-growth-of-deep-tech-through-partnerships-with-prominent-global-vcs.html</link>
			<pubDate>Thu, 31 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1730128295535-25140.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/25140/singapore-commits-s440-million-in-funding-to-drive-growth-of-deep-tech-through-partnerships-with-prominent-global-vcs.html</guid>
		</item>	
				<item>
			<title>Bio-Sourcing secures EIC Accelerator funding to enhance biomanufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/102/24935/bio-sourcing-secures-eic-accelerator-funding-to-enhance-biomanufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/24935/bio-sourcing-secures-eic-accelerator-funding-to-enhance-biomanufacturing.html</link>
			<pubDate>Tue, 24 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dna_life_biotechnology_stockpack_pixabay_scaled_e1658438948290-24935.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/24935/bio-sourcing-secures-eic-accelerator-funding-to-enhance-biomanufacturing.html</guid>
		</item>	
				<item>
			<title>Aevice Health secures $7M Seed Plus funding to expand remote monitoring for chronic respiratory disease</title>
			<atom:link href="https://biospectrumasia.com/news/102/24717/aevice-health-secures-7m-seed-plus-funding-to-expand-remote-monitoring-for-chronic-respiratory-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/24717/aevice-health-secures-7m-seed-plus-funding-to-expand-remote-monitoring-for-chronic-respiratory-disease.html</link>
			<pubDate>Mon, 12 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-24717.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/24717/aevice-health-secures-7m-seed-plus-funding-to-expand-remote-monitoring-for-chronic-respiratory-disease.html</guid>
		</item>	
				<item>
			<title>Singapore EDB aims to strengthen economic competitiveness by attractingÂ investment</title>
			<atom:link href="https://biospectrumasia.com/news/102/23644/singapore-edb-aims-to-strengthen-economic-competitiveness-by-attractinginvestment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/23644/singapore-edb-aims-to-strengthen-economic-competitiveness-by-attractinginvestment.html</link>
			<pubDate>Tue, 30 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gmfd_lm-23644.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/23644/singapore-edb-aims-to-strengthen-economic-competitiveness-by-attractinginvestment.html</guid>
		</item>	
				<item>
			<title>AbbVie expands Biologics Manufacturing Capacity with $223 M investment at Singapore SiteÂ </title>
			<atom:link href="https://biospectrumasia.com/news/102/23629/abbvie-expands-biologics-manufacturing-capacity-with-223-m-investment-at-singapore-site.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/23629/abbvie-expands-biologics-manufacturing-capacity-with-223-m-investment-at-singapore-site.html</link>
			<pubDate>Thu, 25 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/outlook_02rmxzkv-23629.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/23629/abbvie-expands-biologics-manufacturing-capacity-with-223-m-investment-at-singapore-site.html</guid>
		</item>	
				<item>
			<title>Singapore GDMC to expand Global Genetic Medicines Design and Manufacturing Operations</title>
			<atom:link href="https://biospectrumasia.com/news/102/23625/singapore-gdmc-to-expand-global-genetic-medicines-design-and-manufacturing-operations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/23625/singapore-gdmc-to-expand-global-genetic-medicines-design-and-manufacturing-operations.html</link>
			<pubDate>Wed, 24 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/woman_doctor_holding_transparent_glass_bottle_with_dna_icon_inside_her_hand_46370_2407-23625.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/23625/singapore-gdmc-to-expand-global-genetic-medicines-design-and-manufacturing-operations.html</guid>
		</item>	
				<item>
			<title>Bioscience Entrepreneurial Dynamics and Investment Drives</title>
			<atom:link href="https://biospectrumasia.com/news/102/23479/bioscience-entrepreneurial-dynamics-and-investment-drives.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/23479/bioscience-entrepreneurial-dynamics-and-investment-drives.html</link>
			<pubDate>Mon, 18 Dec 2023 18:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/use_it-23479.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/23479/bioscience-entrepreneurial-dynamics-and-investment-drives.html</guid>
		</item>	
				<item>
			<title>Qatar Research, Development, and Innovation (QRDI) Council Elevates Qatar&#039;s Open Innovation Status at SWITCH 2023</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/23269/qatar-research-development-and-innovation-qrdi-council-elevates-qatars-open-innovation-status-at-switch-2023.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/23269/qatar-research-development-and-innovation-qrdi-council-elevates-qatars-open-innovation-status-at-switch-2023.html</link>
			<pubDate>Thu, 02 Nov 2023 21:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/panel_discussion_hosted_by_qrdi_council_at_switch_2023_singapore_2-23269.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/23269/qatar-research-development-and-innovation-qrdi-council-elevates-qatars-open-innovation-status-at-switch-2023.html</guid>
		</item>	
				<item>
			<title>J&amp;J Innovation launches Singapore QuickFire Challenge with the Singapore Economic Development Board</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/23246/jj-innovation-launches-singapore-quickfire-challenge-with-the-singapore-economic-development-board.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/23246/jj-innovation-launches-singapore-quickfire-challenge-with-the-singapore-economic-development-board.html</link>
			<pubDate>Wed, 01 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img20231031151917-23246.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/23246/jj-innovation-launches-singapore-quickfire-challenge-with-the-singapore-economic-development-board.html</guid>
		</item>	
				<item>
			<title>Singapore pledges S$3 million to drive Sustainability OpenInnovation Challenge 2023</title>
			<atom:link href="https://biospectrumasia.com/news/102/23270/singapore-pledges-s3-million-to-drive-sustainability-openinnovation-challenge-2023.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/23270/singapore-pledges-s3-million-to-drive-sustainability-openinnovation-challenge-2023.html</link>
			<pubDate>Tue, 31 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/soic_2023_social_media_banner_1_-23270.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/23270/singapore-pledges-s3-million-to-drive-sustainability-openinnovation-challenge-2023.html</guid>
		</item>	
				<item>
			<title>65LAB enters Singapore biopharma landscape to advance Drug Discovery in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/102/23194/65lab-enters-singapore-biopharma-landscape-to-advance-drug-discovery-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/23194/65lab-enters-singapore-biopharma-landscape-to-advance-drug-discovery-in-singapore.html</link>
			<pubDate>Thu, 05 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_15_-23194.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/23194/65lab-enters-singapore-biopharma-landscape-to-advance-drug-discovery-in-singapore.html</guid>
		</item>	
				<item>
			<title>Singapore&#039;s Center for Healthcare Innovation Evaluation Framework (CHIEF) strives to accelerate innovation adoption</title>
			<atom:link href="https://biospectrumasia.com/news/102/23085/singapores-center-for-healthcare-innovation-evaluation-framework-chief-strives-to-accelerate-innovation-adoption.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/23085/singapores-center-for-healthcare-innovation-evaluation-framework-chief-strives-to-accelerate-innovation-adoption.html</link>
			<pubDate>Fri, 29 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1695963355120-23085.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/23085/singapores-center-for-healthcare-innovation-evaluation-framework-chief-strives-to-accelerate-innovation-adoption.html</guid>
		</item>	
				<item>
			<title>Exploring Synergies: How Biotech Companies and Startups Can Drive Breakthrough Therapies</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/22801/exploring-synergies-how-biotech-companies-and-startups-can-drive-breakthrough-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/22801/exploring-synergies-how-biotech-companies-and-startups-can-drive-breakthrough-therapies.html</link>
			<pubDate>Fri, 28 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1690437881788-22801.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/22801/exploring-synergies-how-biotech-companies-and-startups-can-drive-breakthrough-therapies.html</guid>
		</item>	
				<item>
			<title>ASEAN Businesses to get funding for mediating IP or technology disputes</title>
			<atom:link href="https://biospectrumasia.com/regulatory/102/22666/asean-businesses-to-get-funding-for-mediating-ip-or-technology-disputes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/102/22666/asean-businesses-to-get-funding-for-mediating-ip-or-technology-disputes.html</link>
			<pubDate>Mon, 03 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imgonline_com_ua_compressed_h7litw4n8f-22666.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/102/22666/asean-businesses-to-get-funding-for-mediating-ip-or-technology-disputes.html</guid>
		</item>	
				<item>
			<title>Cedars Sinai sets up its first co-investment partnership with SEEDS Capital in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/102/22432/cedars-sinai-sets-up-its-first-co-investment-partnership-with-seeds-capital-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/22432/cedars-sinai-sets-up-its-first-co-investment-partnership-with-seeds-capital-in-singapore.html</link>
			<pubDate>Fri, 26 May 2023 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/symposium_1-22432.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/22432/cedars-sinai-sets-up-its-first-co-investment-partnership-with-seeds-capital-in-singapore.html</guid>
		</item>	
				<item>
			<title>SomaLogic unveils first-ever proteomics grant program to APAC life sciences researchers</title>
			<atom:link href="https://biospectrumasia.com/news/102/22417/somalogic-unveils-first-ever-proteomics-grant-program-to-apac-life-sciences-researchers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/22417/somalogic-unveils-first-ever-proteomics-grant-program-to-apac-life-sciences-researchers.html</link>
			<pubDate>Mon, 08 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/doctor_with_stethoscope_touching_digital_icons_104033_2-22417.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/22417/somalogic-unveils-first-ever-proteomics-grant-program-to-apac-life-sciences-researchers.html</guid>
		</item>	
				<item>
			<title>Is Asian life sciences industry losing confidence in US after SVB failure?</title>
			<atom:link href="https://biospectrumasia.com/news/102/22099/is-asian-life-sciences-industry-losing-confidence-in-us-after-svb-failure.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/22099/is-asian-life-sciences-industry-losing-confidence-in-us-after-svb-failure.html</link>
			<pubDate>Tue, 14 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22099.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/22099/is-asian-life-sciences-industry-losing-confidence-in-us-after-svb-failure.html</guid>
		</item>	
				<item>
			<title>Asia-Pacific Digital Health Market Investment Continues to be Hot</title>
			<atom:link href="https://biospectrumasia.com/analysis/102/22088/asia-pacific-digital-health-market-investment-continues-to-be-hot.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/102/22088/asia-pacific-digital-health-market-investment-continues-to-be-hot.html</link>
			<pubDate>Fri, 10 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/doctor_using_virtual_application_1134_652-22088.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/102/22088/asia-pacific-digital-health-market-investment-continues-to-be-hot.html</guid>
		</item>	
				<item>
			<title>Singapore witnesses Wharton Global Forum 2023 addressing challenges and opportunities navigating a volatile global economy</title>
			<atom:link href="https://biospectrumasia.com/news/102/22090/singapore-witnesses-wharton-global-forum-2023-addressing-challenges-and-opportunities-navigating-a-volatile-global-economy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/22090/singapore-witnesses-wharton-global-forum-2023-addressing-challenges-and-opportunities-navigating-a-volatile-global-economy.html</link>
			<pubDate>Fri, 10 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imgonline_com_ua_resize_inch_mm_cm_j0yf9pnjqqh-22090.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/22090/singapore-witnesses-wharton-global-forum-2023-addressing-challenges-and-opportunities-navigating-a-volatile-global-economy.html</guid>
		</item>	
				<item>
			<title>Tanaka makes equity contribution for establishing medical venture ecosystem in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/102/21647/tanaka-makes-equity-contribution-for-establishing-medical-venture-ecosystem-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/21647/tanaka-makes-equity-contribution-for-establishing-medical-venture-ecosystem-in-japan.html</link>
			<pubDate>Tue, 20 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine_expenses_healthcare_medicine_health_insurance_stethoscope_money_dollars_banknote_blood_test_tubes_73110_9049-21647.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/21647/tanaka-makes-equity-contribution-for-establishing-medical-venture-ecosystem-in-japan.html</guid>
		</item>	
				<item>
			<title>NHIC lunch of a new initiative to accelerate the adoption of healthtech innovations across healthcare clusters in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/102/21249/nhic-lunch-of-a-new-initiative-to-accelerate-the-adoption-of-healthtech-innovations-across-healthcare-clusters-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/21249/nhic-lunch-of-a-new-initiative-to-accelerate-the-adoption-of-healthtech-innovations-across-healthcare-clusters-in-singapore.html</link>
			<pubDate>Mon, 17 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/21249/nhic-lunch-of-a-new-initiative-to-accelerate-the-adoption-of-healthtech-innovations-across-healthcare-clusters-in-singapore.html</guid>
		</item>	
				<item>
			<title>Revolutionizing healthcare fundraising by matching early-stage startups with potential medical investors </title>
			<atom:link href="https://biospectrumasia.com/opinion/102/21222/revolutionizing-healthcare-fundraising-by-matching-early-stage-startups-with-potential-medical-investors-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/102/21222/revolutionizing-healthcare-fundraising-by-matching-early-stage-startups-with-potential-medical-investors-.html</link>
			<pubDate>Wed, 12 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imgonline_com_ua_twotoone_fwf1ybuqwpbuzm-21222.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/102/21222/revolutionizing-healthcare-fundraising-by-matching-early-stage-startups-with-potential-medical-investors-.html</guid>
		</item>	
				<item>
			<title>ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist</title>
			<atom:link href="https://biospectrumasia.com/news/102/21134/archimed-invests-in-plasmidfactory-a-german-gene-and-cell-therapy-specialist.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/21134/archimed-invests-in-plasmidfactory-a-german-gene-and-cell-therapy-specialist.html</link>
			<pubDate>Wed, 28 Sep 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/33-21134.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/21134/archimed-invests-in-plasmidfactory-a-german-gene-and-cell-therapy-specialist.html</guid>
		</item>	
				<item>
			<title>Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK and Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/102/19058/astrea-bioseparations-makes-critical-infrastructure-investments-in-cambridge-uk-and-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/19058/astrea-bioseparations-makes-critical-infrastructure-investments-in-cambridge-uk-and-singapore.html</link>
			<pubDate>Fri, 17 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-19058.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/19058/astrea-bioseparations-makes-critical-infrastructure-investments-in-cambridge-uk-and-singapore.html</guid>
		</item>	
				<item>
			<title>Cytiva and Pall Corp to invest $1.5B to develop biotech manufacturing capacity in US and UK</title>
			<atom:link href="https://biospectrumasia.com/news/102/18741/cytiva-and-pall-corp-to-invest-1-5b-to-develop-biotech-manufacturing-capacity-in-us-and-uk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/18741/cytiva-and-pall-corp-to-invest-1-5b-to-develop-biotech-manufacturing-capacity-in-us-and-uk.html</link>
			<pubDate>Tue, 03 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharmacy_industry_factory_man_worker_protective_clothing_sterile_working_conditions_88135_6694-18741.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/18741/cytiva-and-pall-corp-to-invest-1-5b-to-develop-biotech-manufacturing-capacity-in-us-and-uk.html</guid>
		</item>	
				<item>
			<title>The UK government launches &#039;UK Life Sciences Vision&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/102/18615/the-uk-government-launches-uk-life-sciences-vision.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/18615/the-uk-government-launches-uk-life-sciences-vision.html</link>
			<pubDate>Mon, 19 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lifesciencesvision_400x300_1-18615.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/18615/the-uk-government-launches-uk-life-sciences-vision.html</guid>
		</item>	
				<item>
			<title>Adlai Nortye raises $100 M (Series D) to accelerate clinical and drug development programs</title>
			<atom:link href="https://biospectrumasia.com/news/102/18593/adlai-nortye-raises-100-m-series-d-to-accelerate-clinical-and-drug-development-programs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/18593/adlai-nortye-raises-100-m-series-d-to-accelerate-clinical-and-drug-development-programs.html</link>
			<pubDate>Thu, 15 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money_dollar_rolled_up_with_pills_flowing_out_isolated_blue_background_high_costs_expensive_medication_concept_copy_space_130265_1928-18593.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/18593/adlai-nortye-raises-100-m-series-d-to-accelerate-clinical-and-drug-development-programs.html</guid>
		</item>	
				<item>
			<title>TVM Capital Healthcare strengthens its leadership in Southeast Asia regions </title>
			<atom:link href="https://biospectrumasia.com/news/102/18512/tvm-capital-healthcare-strengthens-its-leadership-in-southeast-asia-regions-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/18512/tvm-capital-healthcare-strengthens-its-leadership-in-southeast-asia-regions-.html</link>
			<pubDate>Mon, 05 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/farid_fezoua_managing_partner_tvm_capital_healthcare-18512.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/18512/tvm-capital-healthcare-strengthens-its-leadership-in-southeast-asia-regions-.html</guid>
		</item>	
				<item>
			<title>Hong Kong&#039;s biopharma CDMO extends business development services to investors </title>
			<atom:link href="https://biospectrumasia.com/news/102/18293/hong-kongs-biopharma-cdmo-extends-business-development-services-to-investors-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/18293/hong-kongs-biopharma-cdmo-extends-business-development-services-to-investors-.html</link>
			<pubDate>Thu, 03 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr_wayne_tan_ceo_pku_biologics__left__mr_jason_wong-18293.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/18293/hong-kongs-biopharma-cdmo-extends-business-development-services-to-investors-.html</guid>
		</item>	
				<item>
			<title>IFC and Mitsui to invest US$60M in Singapore-based MiCare Health Technologies</title>
			<atom:link href="https://biospectrumasia.com/news/102/18237/ifc-and-mitsui-to-invest-us60m-in-singapore-based-micare-health-technologies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/18237/ifc-and-mitsui-to-invest-us60m-in-singapore-based-micare-health-technologies.html</link>
			<pubDate>Thu, 27 May 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/micare_health_technologies_portal-18237.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/18237/ifc-and-mitsui-to-invest-us60m-in-singapore-based-micare-health-technologies.html</guid>
		</item>	
				<item>
			<title>BIO KOREA 2021 preparing to unravel Biohealth market</title>
			<atom:link href="https://biospectrumasia.com/news/102/18028/bio-korea-2021-preparing-to-unravel-biohealth-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/18028/bio-korea-2021-preparing-to-unravel-biohealth-market.html</link>
			<pubDate>Wed, 21 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_bio_korea-18028.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/18028/bio-korea-2021-preparing-to-unravel-biohealth-market.html</guid>
		</item>	
				<item>
			<title>China&#039;s AffaMed Therapeutics completes US$170M Series B financing </title>
			<atom:link href="https://biospectrumasia.com/news/102/17876/chinas-affamed-therapeutics-completes-us170m-series-b-financing-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/17876/chinas-affamed-therapeutics-completes-us170m-series-b-financing-.html</link>
			<pubDate>Tue, 30 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dollar_money_bag_stethoscope_health_life_insurance_financing_concept_72572_1566-17876.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/17876/chinas-affamed-therapeutics-completes-us170m-series-b-financing-.html</guid>
		</item>	
				<item>
			<title>VISEN raises $150M in Series B to accelerate innovative endocrinology therapies in Greater China</title>
			<atom:link href="https://biospectrumasia.com/news/102/17400/visen-raises-150m-in-series-b-to-accelerate-innovative-endocrinology-therapies-in-greater-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/17400/visen-raises-150m-in-series-b-to-accelerate-innovative-endocrinology-therapies-in-greater-china.html</link>
			<pubDate>Mon, 11 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik34-17400.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/17400/visen-raises-150m-in-series-b-to-accelerate-innovative-endocrinology-therapies-in-greater-china.html</guid>
		</item>	
				<item>
			<title>Vietnam boosts innovation and startup ecosystem</title>
			<atom:link href="https://biospectrumasia.com/news/102/17403/vietnam-boosts-innovation-and-startup-ecosystem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/17403/vietnam-boosts-innovation-and-startup-ecosystem.html</link>
			<pubDate>Mon, 11 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ttg_1_-17403.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/17403/vietnam-boosts-innovation-and-startup-ecosystem.html</guid>
		</item>	
				<item>
			<title>Heritas Capital launches $30M fund for early stage startups in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/102/17380/heritas-capital-launches-30m-fund-for-early-stage-startups-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/17380/heritas-capital-launches-30m-fund-for-early-stage-startups-in-asia.html</link>
			<pubDate>Thu, 07 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/person_using_tablet_53876_13420-17380.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/17380/heritas-capital-launches-30m-fund-for-early-stage-startups-in-asia.html</guid>
		</item>	
				<item>
			<title>Thailand witnessed $1.7 billion investment in Bio-Circular-Green economic activities (BCG) during Jan-Sep 2020</title>
			<atom:link href="https://biospectrumasia.com/news/102/17352/thailand-witnessed-1-7-billion-investment-in-bio-circular-green-economic-activities-bcg-during-jan-sep-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/17352/thailand-witnessed-1-7-billion-investment-in-bio-circular-green-economic-activities-bcg-during-jan-sep-2020.html</link>
			<pubDate>Thu, 31 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dsc_6539_5fe403c2da244-17352.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/17352/thailand-witnessed-1-7-billion-investment-in-bio-circular-green-economic-activities-bcg-during-jan-sep-2020.html</guid>
		</item>	
				<item>
			<title>Mednefits enhances employee benefits in Singapore and Malaysia</title>
			<atom:link href="https://biospectrumasia.com/news/102/17129/mednefits-enhances-employee-benefits-in-singapore-and-malaysia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/17129/mednefits-enhances-employee-benefits-in-singapore-and-malaysia.html</link>
			<pubDate>Tue, 17 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5f363119dbbe844e81eecf0f_mednefits_image_cache_1_-17129.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/17129/mednefits-enhances-employee-benefits-in-singapore-and-malaysia.html</guid>
		</item>	
				<item>
			<title>Thailand to discuss Biorisk Mitigation &amp; Infection Control at Asean ISSA Global Biorisk Symposium</title>
			<atom:link href="https://biospectrumasia.com/news/102/17113/thailand-to-discuss-biorisk-mitigation-infection-control-at-asean-issa-global-biorisk-symposium.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/17113/thailand-to-discuss-biorisk-mitigation-infection-control-at-asean-issa-global-biorisk-symposium.html</link>
			<pubDate>Fri, 13 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/issa_global_biorisk_symposium-17113.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/17113/thailand-to-discuss-biorisk-mitigation-infection-control-at-asean-issa-global-biorisk-symposium.html</guid>
		</item>	
				<item>
			<title>Key insights from investors to build successful start-ups unveiled: SPAG Study</title>
			<atom:link href="https://biospectrumasia.com/news/102/17117/key-insights-from-investors-to-build-successful-start-ups-unveiled-spag-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/17117/key-insights-from-investors-to-build-successful-start-ups-unveiled-spag-study.html</link>
			<pubDate>Fri, 13 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/top_5_spag_recommendations_investor_insights_1_-17117.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/17117/key-insights-from-investors-to-build-successful-start-ups-unveiled-spag-study.html</guid>
		</item>	
				<item>
			<title>Novasep invests â‚¬6.5 million in accelerating API manufacturing in France</title>
			<atom:link href="https://biospectrumasia.com/news/102/17099/novasep-invests-6-5-million-in-accelerating-api-manufacturing-in-france.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/17099/novasep-invests-6-5-million-in-accelerating-api-manufacturing-in-france.html</link>
			<pubDate>Tue, 10 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/_dghk_1_2_2_1_-17099.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/17099/novasep-invests-6-5-million-in-accelerating-api-manufacturing-in-france.html</guid>
		</item>	
				<item>
			<title>Siemens Healthineers drives digitization in healthcare by investing in Indian market</title>
			<atom:link href="https://biospectrumasia.com/news/102/16972/siemens-healthineers-drives-digitization-in-healthcare-by-investing-in-indian-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/16972/siemens-healthineers-drives-digitization-in-healthcare-by-investing-in-indian-market.html</link>
			<pubDate>Wed, 21 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/portlet_pr_20190131006shs_06048805_8-16972.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/16972/siemens-healthineers-drives-digitization-in-healthcare-by-investing-in-indian-market.html</guid>
		</item>	
				<item>
			<title> Vetter continues its long-term investment strategy to sustain future growth</title>
			<atom:link href="https://biospectrumasia.com/news/102/16980/-vetter-continues-its-long-term-investment-strategy-to-sustain-future-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/16980/-vetter-continues-its-long-term-investment-strategy-to-sustain-future-growth.html</link>
			<pubDate>Wed, 21 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rsz_vetter_continues_its_long_term_investment_strategy-16980.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/16980/-vetter-continues-its-long-term-investment-strategy-to-sustain-future-growth.html</guid>
		</item>	
				<item>
			<title>Strong profitable growth at Sartorius</title>
			<atom:link href="https://biospectrumasia.com/company-results/102/16961/strong-profitable-growth-at-sartorius.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/102/16961/strong-profitable-growth-at-sartorius.html</link>
			<pubDate>Tue, 20 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/life_science_festival_herostage_data__1603170473_66927-16961.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/102/16961/strong-profitable-growth-at-sartorius.html</guid>
		</item>	
				<item>
			<title>CStone announces completion of $200 million share sale to Pfizer</title>
			<atom:link href="https://biospectrumasia.com/news/102/16896/cstone-announces-completion-of-200-million-share-sale-to-pfizer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/16896/cstone-announces-completion-of-200-million-share-sale-to-pfizer.html</link>
			<pubDate>Mon, 12 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/close_up_pharmacist_man_hand_shaking_counter_with_patient_customer_42708_27-16896.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/16896/cstone-announces-completion-of-200-million-share-sale-to-pfizer.html</guid>
		</item>	
				<item>
			<title>TerumoÂ BCT launchesÂ ATMIÂ Grant 2020 forÂ APAC</title>
			<atom:link href="https://biospectrumasia.com/news/102/16859/terumobct-launchesatmigrant-2020-forapac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/102/16859/terumobct-launchesatmigrant-2020-forapac.html</link>
			<pubDate>Tue, 06 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/final_tbct_logo_cmyk_horizontal_1_-16859.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/102/16859/terumobct-launchesatmigrant-2020-forapac.html</guid>
		</item>	
				</channel>
</rss>
